Clinical trial

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

NCT04822298

Study summary

ClinicalTrials.gov

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention AMG 160 Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-08-31

PhasePHASE1

Conditions

Non-small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

NSCLCverified · MONDO: non-small cell lung carcinoma

Interventions

AMG 160DRUG

Sponsors & collaborators

Amgenlead sponsor

Mapped research locations

HoustonTexas, United States1 ViennaAustria1 SalzburgAustria1 CamperdownNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04822298 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.